|Day Low/High||58.18 / 59.84|
|52 Wk Low/High||51.72 / 77.03|
As I've stated before, I'm looking for names that are 'stupid cheap', and I'm not sure we're there yet.
It's online, off-price, or nothing in the time of the coronavirus.
Here are a number of things that I'm watching now.
With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
KLA Corp. and Target already have triggered entry points, while CVS Health soon could.
Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
We play the game in front of us. We try to excel in the environment provided.
This rally has been industry, not sector led, and it is all based on technology, whether or not market leaders reside within the Tech sector or not.
Teladoc said has been especially in demand this flu season.
RMPIA ended January up 0.8%, but now the damage from the Wuhan virus is weighing on the future.
While both companies appear like winners, WBA should have more to gain because of its discounted price.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
The upcoming quarterly report for WBA might be a market mover, but the charts and indicators of CVS show a healthy stock ready to rise.
What I suggest individual investors do is give their portfolios a physical. Like a visit to the doctor.
Let's review 2019 performance of RMPIA in relation to stock indexes and see what's ahead.
This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.
It seemed to happen overnight. People watched. People listened. People cared. About what? Individual stocks.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
There is no doubt in my mind that the firm is executing at a high level.
Now, many Real Money Post Industrial Average stocks should see a boost from the holiday splurge by shoppers.
I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.
I like the name, and I like the progress that CVS is making. This stock can go higher.
Even before reporting better-than-expected third-quarter results, the pharmacy giant was seeing more aggressive buying of its shares.
OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.
Disney, Qualcomm and Square are among 75 key reports we are watching.